These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9612618)

  • 1. [Combination therapy in oncology (multimodal treatment) in pancreatic tumors].
    Ihse I; Andersson R; Axelson J; Hansson L
    Chirurg; 1998 Apr; 69(4):366-70. PubMed ID: 9612618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection and radiochemotherapy of pancreatic cancer--the future?
    Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
    Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy in operable pancreatic cancer.
    Wente MN; Büchler P; Friess H; Büchler MW
    Swiss Surg; 2002; 8(2):74-80. PubMed ID: 12013694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.
    Iott MJ; Corsini MM; Miller RC
    Clin J Oncol Nurs; 2008 Aug; 12(4):599-605. PubMed ID: 18676327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of adjuvant chemoradiotherapy in the therapeutic strategy of exocrine adenocarcinoma of the pancreas].
    Mornex F; Partensky C; Bedenne L
    Cancer Radiother; 1997; 1(5):542-6. PubMed ID: 9587387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for pancreatic cancer.
    Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
    Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
    Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB
    Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiotherapy for pancreatic adenocarcinoma.
    Sunamura M; Kobari M; Lozonschi L; Egawa S; Matsuno S
    J Hepatobiliary Pancreat Surg; 1998; 5(2):151-6. PubMed ID: 9745081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant postoperative radiation therapy +/- 5-FU in resected carcinoma of the pancreas.
    Foo ML; Gunderson LL
    Hepatogastroenterology; 1998; 45(21):613-23. PubMed ID: 9684106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgery in pancreatic cancer.
    Buanes TA
    World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
    Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
    Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
    Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
    Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
    J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
    Reni M
    World J Gastroenterol; 2010 Oct; 16(39):4883-7. PubMed ID: 20954273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment for resectable pancreatic cancer.
    Chua YJ; Cunningham D
    J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.